{
    "eid": "2-s2.0-85140853192",
    "title": "mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model",
    "cover-date": "2022-10-14",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology and Allergy",
            "@code": "2723",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        }
    ],
    "keywords": [
        "cancer immunotherapy",
        "melanomas",
        "mRNA vaccine",
        "type I interferon",
        "unmodified nucleosides"
    ],
    "authors": [
        "Chutamath Sittplangkoon",
        "Mohamad Gabriel Alameh",
        "Drew Weissman",
        "Paulo J.C. Lin",
        "Ying K. Tam",
        "Eakachai Prompetchara",
        "Tanapat Palaga"
    ],
    "citedby-count": 2,
    "ref-count": 56,
    "ref-list": [
        "Immune targets and neoantigens for cancer immunotherapy and precision medicine",
        "Peptide vaccine: Progress and challenges",
        "Peptide-based materials for cancer immunotherapy",
        "The peptide vaccine of the future",
        "Cancer DNA vaccines: current preclinical and clinical developments and future perspectives",
        "Immunotherapy in prostate cancer",
        "Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer",
        "Novel pancreatic cancer vaccines could unleash the army within",
        "mRNA-based cancer vaccines: A therapeutic strategy for the treatment of melanoma patients",
        "Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer",
        "The dawn of mRNA vaccines: The COVID-19 case",
        "Messenger RNA regulation: To translate or to degrade",
        "Deep sequencing shows multiple oligouridylations are required for 3\u2019 to 5\u2019 degradation of histone mRNAs on polyribosomes",
        "Type I interferon in chronic virus infection and cancer",
        "Peptide-mediated RNA delivery: A novel approach for enhanced transfection of primary and post-mitotic cells",
        "Adjuvant effects of a sequence-engineered mRNA vaccine: Translational profiling demonstrates similar human and murine innate response",
        "mRNA vaccines - a new era in vaccinology",
        "Non-immunotherapy application of LNP-mRNA: Maximizing efficacy and safety",
        "N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice",
        "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability",
        "Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation",
        "Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in Large animals",
        "Quantifying immune-based counterselection of somatic mutations",
        "Mutanome engineered RNA immunotherapy: Towards patient-centered tumor vaccination",
        "Mutant MHC class II epitopes drive therapeutic immune responses to cancer",
        "Exploiting the mutanome for tumor vaccination",
        "A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice",
        "A facile method for the removal of dsRNA contaminant from In vitro-transcribed mRNA",
        "Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes",
        "Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy",
        "Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma",
        "Blocking monoclonal antibodies specific for mouse IFN-alpha/beta receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection",
        "Maternal type-I interferon signaling adversely affects the microglia and the behavior of the offspring accompanied by increased sensitivity to stress",
        "Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity",
        "Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines",
        "cDC1 prime and are licensed by CD4(+) T cells to induce anti-tumour immunity",
        "The role of CD40 and CD154/CD40L in dendritic cells",
        "Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses",
        "RNA Mediated toll-like receptor stimulation in health and disease",
        "Trained immunity, tolerance, priming and differentiation: distinct immunological processes",
        "The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling",
        "The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2",
        "New insights into M1/M2 macrophages: key modulators in cancer progression",
        "Immune system: a double-edged sword in cancer",
        "Type I IFN activating type I dendritic cells for antitumor immunity",
        "CD3(+)CD4(-)CD8(-) (Double-negative) T cells in inflammation, immune disorders and cancer",
        "Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment",
        "FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells",
        "T Cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition",
        "Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2",
        "PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta",
        "Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells",
        "CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function",
        "Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts",
        "Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency",
        "Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60003711",
            "affilname": "University of Pennsylvania Perelman School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003711",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Vancouver",
            "@id": "114122292",
            "affilname": "Acuitas Therapeutics",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114122292",
            "affiliation-country": "Canada"
        }
    ],
    "funding": [
        "Chulaongkorn Academic Advancement",
        "Institutional Development, Research and Innovation",
        "NSRF",
        "National Science, Research and Innovation Fund",
        "PMU-B",
        "Ratchadaphiseksomphot Endowment Fund",
        "Science Achievement Scholarship of Thailand",
        "Chulalongkorn University",
        "National Research Council of Thailand",
        "SAST"
    ]
}